Related references
Note: Only part of the references are listed.Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity
Susanne Wilde et al.
BLOOD (2009)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Survivin as a universal tumor antigen for novel cancer immunotherapy Functions of a killer clone
Nicole A. Aqui et al.
CANCER BIOLOGY & THERAPY (2008)
A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis
Rikke Baek Sorensen et al.
CANCER BIOLOGY & THERAPY (2008)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of p53 Overexpression on Cancers and Recognition by Anti-p53 T Cell Receptor-Transduced T Cells
Marc R. Theoret et al.
HUMAN GENE THERAPY (2008)
Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette
Matthias Leisegang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Adoptive T cell therapy for cancer in the clinic
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
CD8+ T cells reactive to survivin antigen in patients with multiple myeloma
Matthias Grube et al.
CLINICAL CANCER RESEARCH (2007)
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma
Christina M. Coughlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes
Laura A. Johnson et al.
JOURNAL OF IMMUNOLOGY (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells
KBJ Scholten et al.
CLINICAL IMMUNOLOGY (2006)
Generation of tumor-specific T-cell therapies
E Morris et al.
BLOOD REVIEWS (2006)
Melanoma-associated antigen tyrosinase but not Melan-A/MART-1 expression and presentation dissociate during the heat shock response
V Milani et al.
INTERNATIONAL IMMUNOLOGY (2005)
Identification of a survivin-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes
S Siegel et al.
LEUKEMIA (2004)
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells
SM Schmidt et al.
BLOOD (2003)
Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells
M Oelke et al.
NATURE MEDICINE (2003)
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-speciflic T cells
JJ Molldrem et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Validating survivin as a cancer therapeutic target
DC Altieri
NATURE REVIEWS CANCER (2003)
CD8(+) T cell tolerance and cancer immunotherapy
KE de Visser et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Share Paper
